SOURCE: COR Medical Technologies

COR Medical Technologies

November 04, 2014 12:05 ET

COR Medical Technologies Launches System to Improve Cardiovascular Outcomes

Built for Support at Time of Care, Particularly With Mobile Devices

HOUSTON, TX--(Marketwired - Nov 4, 2014) - COR Medical Technologies (COR) introduces CORcare™, a comprehensive instant outcome support system for rapid and accurate diagnosis, treatment, and follow-up management of patients with acute and chronic, common and rare diseases involving the cardiovascular system. It was developed by Vincent Friedewald, M.D., F.A.C.C., with the support of an internationally-acclaimed Senior Editorial Board. COR is a vast, one-of-a-kind relational database comprising thousands of signs and symptoms, imaging findings, laboratory abnormalities, electrocardiographic results, body area networking (BAN) measures, and genomics, as well as drugs and devices used for treatment. CORcare is available to healthcare professionals on a variety of technology platforms including mobile devices. Targeted users of CORcare include physicians, emergency medical technicians, nurse practitioners, physician assistants, nurses, physician groups, hospitals, and academic institutions and their students.

CORcare helps healthcare professionals consider all possible conditions associated with any single or combination of clinical features for rapid assistance in differential diagnosis and narrowing down to the final diagnosis. CORcare is the first system to embed ACCF/AHA Guidelines specific to data points within each condition, providing instant graded opinions of leading authorities. This feature fully supports and uses the "Guideline Directed Medical Therapy (GDMT)" initiative of the AHA and ACC. Also based on ACCF/AHA Guidelines, CORcare provides order sets for many of the common conditions, a feature proven to reduce physician ordering time by up to 50 percent. After diagnoses and management strategies are in place, CORcare provides a secure platform for patient follow-up -- called MyCOR™ -- which includes tools to improve medication adherence and other telemedicine functions.

"My vision for creating CORcare is straightforward: improving patient outcomes by combining our proprietary COR database with the incredible new communication technologies that reach almost everyone. By better outcomes, we target fewer events, greater longevity, and better quality of life for our patients," said Dr. Friedewald. "A perfect example is reducing the need for hospitalizations for heart failure, a goal that benefits everyone."

CORcare has other applications as well, all aimed at improving outcomes, such as a new and innovative way for professional education using "Structured Primary Experiential Learning (SPEL)," which Dr. Vincent Friedewald developed while teaching The Principles of Mass Communications at the University of Notre Dame.

CORcare also provides a robust means for gathering otherwise unattainable clinical outcome data directly from patients themselves. By incorporating the new ICD-10 coding requirements and appropriate XML structures in database construction, CORcare can be integrated with electronic health records.

"I am excited to be involved with CORcare for many reasons, the most important being the need for the health profession to fundamentally transform the way we communicate both internally and with our patients," said James Young, M.D., Professor of Medicine and Executive Dean, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Chairman, Cleveland Clinic Endocrinology & Metabolism Institute in Cleveland, and a member of the COR Senior Editorial Board. "The medical world is changing in many ways, and new digital technology offers many effective avenues to accommodate these changes. Take, for example, medical education, which is in need of a new model for competency-based, learner-centered systems (Academic Medicine 2013;88:1418-1423). This is one of the many goals we can achieve with the innovative approach that COR is using."

Currently, there are three options to sign up for CORcare including standard, premium, and organization. The standard option, which is read-only, is free. The premium option, which is currently available for a 30-day free trial, is $240 a year. Organizations that want to give a large number of their healthcare professionals access to CORcare can get a personalized quote by sending an email to info@cormedtec.com. More detail on membership packages and features is available at www.cormedtec.com/pricing-setup.

Vincent Friedewald has more than 40 years of experience in cardiovascular medicine, including patient care, research, teaching, and writing. He has authored nine books, including the upcoming Clinical Guide to Cardiovascular Disease (Springer, London), and serves as an Associate Editor of The American Journal of Cardiology. He currently has faculty appointments at the University of Notre Dame and Indiana University School of Medicine-South Bend.

About COR Medical Technologies
COR Medical Technologies offers CORcare™, the world's most comprehensive instant outcome support system for heart disease. It was developed by healthcare practitioners and is designed for use at the time of care to improve diagnostic accuracy and treatment practices to optimize patient outcomes. The outcome support system is available on a variety of platforms including mobile devices. For more information please visit www.cormedtec.com. Also follow COR Medical Technologies on LinkedIn https://www.linkedin.com/company/cor-medical-technologies and Twitter at www.twitter.com/cormedtec.

Contact Information